Search Results - "Subleski, J."

Refine Results
  1. 1
  2. 2

    Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses by Walls, Jessica F, Subleski, Jeff J, Palmieri, Erika M, Gonzalez-Cotto, Marieli, Gardiner, Clair M, McVicar, Daniel W, Finlay, David K

    Published in eLife (19-08-2020)
    “…Natural Killer (NK) cells have an important role in immune responses to viruses and tumours. Integrating changes in signal transduction pathways and cellular…”
    Get full text
    Journal Article
  3. 3

    Immunotherapy of cancer by IL-12-based cytokine combinations by Weiss, Jonathan M, Subleski, Jeff J, Wigginton, Jon M, Wiltrout, Robert H

    Published in Expert opinion on biological therapy (01-11-2007)
    “…Cancer is a multi-faceted disease comprising complex interactions between neoplastic and normal cells. Over the past decade, there has been considerable…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Application of tissue-specific NK and NKT cell activity for tumor immunotherapy by Subleski, Jeff J, Wiltrout, Robert H, Weiss, Jonathan M

    Published in Journal of autoimmunity (01-11-2009)
    “…Abstract Natural killer (NK) and NKT cells are a first line of defense against pathogens and transformed cells. However, dysregulation of their function can…”
    Get full text
    Journal Article
  6. 6

    Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy by Subleski, Jeff J, Scarzello, Anthony J, Alvord, W. Gregory, Jiang, Qun, Stauffer, Jimmy K, Kronfli, Anthony, Saleh, Bahara, Back, Timothy, Weiss, Jonathan M, Wiltrout, Robert H

    Published in Journal of hepatology (01-11-2015)
    “…Abstract Background & Aims Liver inflammatory diseases associated with cancer promoting somatic oncogene mutations are increasing in frequency. Preclinical…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Interleukin-15 Enhances Proteasomal Degradation of Bid in Normal Lymphocytes: Implications for Large Granular Lymphocyte Leukemias by HODGE, Deborah L, JUN YANG, LOUGHRAN, Thomas P, YOUNG, Howard A, BUSCHMAN, Matthew D, SCHAUGHENCY, Paul M, HONG DANG, BERE, William, YILI YANG, SAVAN, Ram, SUBLESKI, Jeff J, YIN, Xiao-Ming

    Published in Cancer research (Chicago, Ill.) (01-05-2009)
    “…Large granular lymphocyte (LGL) leukemia is a clonal proliferative disease of T and natural killer (NK) cells. Interleukin (IL)-15 is important for the…”
    Get full text
    Journal Article
  9. 9

    Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities by Chan, Tim, Back, Timothy C, Subleski, Jeffrey J, Weiss, Jonathan M, Ortaldo, John R, Wiltrout, Robert H

    Published in PloS one (13-03-2012)
    “…The liver is an immunologically unique organ containing tolerogenic dendritic cells (DC) that maintain an immunosuppressive microenvironment. Although systemic…”
    Get full text
    Journal Article
  10. 10

    IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation by Geiselhart, Lisa A, Humphries, Courtney A, Gregorio, Theresa A, Mou, Sherry, Subleski, Jeffrey, Komschlies, Kristin L

    Published in The Journal of immunology (1950) (01-03-2001)
    “…IL-7 is vital for the development of the immune system and profoundly enhances the function of mature T cells. Chronic administration of IL-7 to mice markedly…”
    Get full text
    Journal Article
  11. 11

    IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy by Wigginton, J M, Gruys, E, Geiselhart, L, Subleski, J, Komschlies, K L, Park, J W, Wiltrout, T A, Nagashima, K, Back, T C, Wiltrout, R H

    Published in The Journal of clinical investigation (01-07-2001)
    “…Systemic administration of IL-12 and intermittent doses of IL-2 induce complete regression of metastatic murine renal carcinoma. Here, we show that overt tumor…”
    Get full text
    Journal Article
  12. 12

    Co-expression of TNFR2 and CD25 identifies more of the functional CD4⁺FOXP3⁺ regulatory T cells in human peripheral blood by Chen, Xin, Subleski, Jeffrey J, Hamano, Ryoko, Howard, O.M. Zack, Wiltrout, Robert H, Oppenheim, Joost J

    Published in European journal of immunology (01-04-2010)
    “…Previously, we found that co-expression of CD25 and TNFR2 identified the most suppressive subset of mouse Treg. In this study, we report that human peripheral…”
    Get full text
    Journal Article
  13. 13

    The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death by Hodge, Deborah L, Subleski, Jeff J, Reynolds, Della A, Buschman, Matthew D, Schill, William B, Burkett, Mark W, Malyguine, Anatoli M, Young, Howard A

    Published in Journal of interferon & cytokine research (01-10-2006)
    “…The proinflammatory cytokine, interleukin-18 (IL-18), is a natural killer (NK) cell activator that induces NK cell cytotoxicity and interferon-gamma…”
    Get more information
    Journal Article
  14. 14

    Peroxisome proliferator-activated receptor-γ and its ligands attenuate biologic functions of human natural killer cells by Zhang, Xia, Rodriguez-Galán, Maria Cecilia, Subleski, Jeff J., Ortaldo, John R., Hodge, Deborah L., Wang, Ji-Ming, Shimozato, Osamu, Reynolds, Della A., Young, Howard A.

    Published in Blood (15-11-2004)
    “…Interferon-γ (IFN-γ) production and cytolytic activity are 2 major biologic functions of natural killer (NK) cells that are important for innate immunity. We…”
    Get full text
    Journal Article
  15. 15

    Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells by Chen, Xin, Hamano, Ryoko, Subleski, Jeffrey J, Hurwitz, Arthur A, Howard, O M Zack, Oppenheim, Joost J

    Published in The Journal of immunology (1950) (01-07-2010)
    “…Our previous study showed that TNFR2 is preferentially expressed by CD4(+)FoxP3(+) regulatory T cells (Tregs), and expression of this receptor identified…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy by Weiss, Jonathan M, Subleski, Jeff J, Back, Tim, Chen, Xin, Watkins, Stephanie K, Yagita, Hideo, Sayers, Thomas J, Murphy, William J, Wiltrout, Robert H

    Published in The Journal of immunology (1950) (15-06-2014)
    “…Fas ligand expression in certain tumors has been proposed to contribute to immunosuppression and poor prognosis. However, immunotherapeutic approaches may…”
    Get full text
    Journal Article
  18. 18

    Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L by Lee, J.-K., Seki, N., Sayers, T.J., Subleski, J., Gruys, E.M., Murphy, W.J., Wiltrout, R.H.

    Published in Cellular Immunology (01-06-2005)
    “…CD40, a member of the TNF receptor superfamily, is expressed on B cells, dendritic cells, and some tumor cells, including melanoma and bladder carcinoma. In…”
    Get full text
    Journal Article
  19. 19

    RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter by Lai, Jenn-Haung, Horvath, GyöRgyi, Subleski, Jeff, Bruder, Joseph, Ghosh, Paritosh, Tan, Tse-Hua

    Published in Molecular and Cellular Biology (01-08-1995)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  20. 20

    Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver by SUBLESKI, Jeff J, HALL, Veronica L, BACK, Timothy C, ORTALDO, John R, WILTROUT, Robert H

    Published in Cancer research (Chicago, Ill.) (15-11-2006)
    “…The use of interleukin-18 (IL-18) together with IL-12 induced high levels of IFN-gamma in tumor-bearing mice and regression of liver tumors that was abolished…”
    Get full text
    Journal Article